+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Growth Opportunities in Gene Therapies, Cancer, Disease Treatment & Monitoring, Surgical Applications and Cosmetics

  • ID: 5313379
  • Report
  • January 2021
  • Region: Global
  • 40 Pages
  • Frost & Sullivan

FEATURED COMPANIES

  • Belite Bio Inc.
  • Biolinerx
  • Immunocore
  • Locate Bio Limited
  • Mussel Polymers Inc.
  • Renovorx
  • MORE

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) consists of insights across gene therapies, cancer, neurological, allergic and respiratory diseases treatment and monitoring. Further, novel drugs, drug delivery systems, surgical support applications, artificial intelligence-based imaging, as well as telehealth systems are discussed. Some innovations cover the upcoming innovations in cosmetics, acne treatment, food packing, and natural extract processing technologies

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Belite Bio Inc.
  • Biolinerx
  • Immunocore
  • Locate Bio Limited
  • Mussel Polymers Inc.
  • Renovorx
  • MORE

Innovations in Life Sciences, Health & Wellness

  • Renovorx, US
  • Hoth Therapeutics, US
  • Swedish Orphan Biovitrum Ab, Sweden
  • Tyto Care, US
  • Scopus Biopharma Inc., US
  • Biolinerx, Israel
  • Innodem Neurosciences, Canada
  • Children’s Hospital of Philadelphia & University of Pennsylvania, US
  • Neurent Medical, Ireland
  • Immunocore, UK
  • MIVI Neuroscience, US
  • Bioclinica, US
  • Belite Bio Inc., Ca, US
  • Plus Therapeutics Inc., US
  • Biocryst Pharmaceuticals Inc., US
  • Verrica Pharmaceuticals Inc., US
  • Lygenesis, US
  • Sebela Pharmaceuticals, US
  • Helix, US
  • VOR Biopharma, UK
  • Sustainable Adhesive Products™ Ltd., Netherlands
  • Mussel Polymers Inc., US
  • Bio-Botanica Inc., US
  • Lachemi Chemorgs, India
  • Locate Bio Limited, UK
  • Viiv Healthcare, US

Key Contacts

  • Legal Disclaimer
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Belite Bio Inc.
  • Bio-Botanica Inc.
  • Bioclinica
  • Biocryst Pharmaceuticals Inc.
  • Biolinerx
  • Children’s Hospital of Philadelphia & University of Pennsylvania
  • Helix
  • Hoth Therapeutics
  • Immunocore
  • Innodem Neurosciences
  • Lachemi Chemorgs
  • Locate Bio Limited
  • Lygenesis
  • MIVI Neuroscience
  • Mussel Polymers Inc.
  • Neurent Medical
  • Plus Therapeutics Inc.
  • Renovorx
  • Scopus Biopharma Inc.
  • Sebela Pharmaceuticals
  • Sustainable Adhesive Products Ltd.
  • Swedish Orphan Biovitrum Ab
  • Tyto Care
  • Verrica Pharmaceuticals Inc.
  • Viiv Healthcare
  • VOR Biopharma
Note: Product cover images may vary from those shown
Adroll
adroll